Literature DB >> 24520948

The state of measles and rubella in the WHO European Region, 2013.

M Muscat1, A Shefer, M Ben Mamou, R Spataru, D Jankovic, S Deshevoy, R Butler, D Pfeifer.   

Abstract

Measles and rubella persist in the World Health Organization European Region despite long-standing and widespread use of vaccines against them. Our aim was to review the epidemiology of measles and rubella in relation to the goal of eliminating these diseases from the Region by 2015. We report on the number of measles and rubella cases by country in 2012 and present an analysis of preliminary measles and rubella surveillance data for 2013. We analysed data of these diseases for 2013 by age group, diagnosis confirmation (clinical, laboratory-confirmed and epidemiologically linked), and vaccination, hospitalization and importation status. We also report on measles-related deaths. For 2012, there were 26,785 [corrected] measles cases and 29,601 rubella cases reported in the Region. For 2013, these figures were 31,520 and 39,367 respectively. Most measles cases in 2013 (96%; n = 30,178) were reported by nine countries: Georgia (7830), Germany (1773), Italy (2216), the Netherlands (2499), Romania (1074), the Russian Federation (2174), Turkey (7404), Ukraine (3308) and the United Kingdom (1900). In 2013, most measles cases were among unvaccinated persons and over one in three patients were aged 20 years and older. For 2013, almost all rubella cases were reported by Poland (n = 38,585; 98%). High population immunity and high-quality surveillance are the cornerstones to eliminate measles and rubella. Without sustained political commitment and accelerated action by Member States and partners, the elimination of measles and rubella in the WHO European Region may not be achieved.
© 2014 The Authors Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectious Diseases The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.

Entities:  

Keywords:  Disease elimination; genotyping; measles; rubella; surveillance; vaccination

Mesh:

Year:  2014        PMID: 24520948     DOI: 10.1111/1469-0691.12584

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  25 in total

Review 1.  Immunization of HIV-infected adult patients - French recommendations.

Authors:  Anne Frésard; Amandine Gagneux-Brunon; Frédéric Lucht; Elisabeth Botelho-Nevers; Odile Launay
Journal:  Hum Vaccin Immunother       Date:  2016-07-13       Impact factor: 3.452

2.  Apropos "Incorporating immunizations into routine obstetric care to facilitate health care practitioners in implementing maternal immunization recommendations".

Authors:  Subhash C Arya; Nirmala Agarwal; Shekhar Agarawal
Journal:  Hum Vaccin Immunother       Date:  2014-03-17       Impact factor: 3.452

Review 3.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2021-11-22

4.  Surveillance and vaccination coverage of measles and rubella in Northern Italy.

Authors:  Antonella Amendola; Laura Bubba; Antonio Piralla; Sandro Binda; Alessandro Zanetti; Elena Pariani; Alberto Ranghiero; Marta Premoli; Laura Pellegrinelli; Liliana Coppola; Maria Gramegna; Fausto Baldanti; Alessandro Zanetti
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

5.  Heterogeneity in social and epidemiological factors determines the risk of measles outbreaks.

Authors:  Paolo Bosetti; Piero Poletti; Massimo Stella; Bruno Lepri; Stefano Merler; Manlio De Domenico
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-17       Impact factor: 11.205

Review 6.  The personal touch: strategies toward personalized vaccines and predicting immune responses to them.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; Nathaniel D Lambert; Iana H Haralambieva; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2014-04-04       Impact factor: 5.217

7.  Quantifying the impact of mass vaccination programmes on notified cases in the Netherlands.

Authors:  M van Wijhe; A D Tulen; H Korthals Altes; S A McDonald; H E de Melker; M J Postma; J Wallinga
Journal:  Epidemiol Infect       Date:  2018-03-14       Impact factor: 4.434

8.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2020-04-20

9.  Descriptive epidemiology of measles cases in Bauchi State, 2013-2018.

Authors:  Polycarp Uchechukwu Ori; Ayo Adebowale; Chukwuma David Umeokonkwo; Ugochukwu Osigwe; Muhammad Shakir Balogun
Journal:  BMC Public Health       Date:  2021-07-05       Impact factor: 3.295

10.  The World Health Organization Measles Programmatic Risk Assessment Tool-Romania, 2015.

Authors:  Jennifer L Kriss; Aurora Stanescu; Adriana Pistol; Cassandra Butu; James L Goodson
Journal:  Risk Anal       Date:  2016-07-20       Impact factor: 4.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.